Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer

<div>The expression level of serum miR-629 was significantly increased in patients with NSCLC compared to that in nonmalignant lung disease and healthy controls.</div>

Disease Markers

fig1

Figure 1

Figure 1: Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer 